Concepts (89)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tympanic Membrane | 2 | 2020 | 225 | 0.700 |
Why?
|
| Keratinocytes | 1 | 2020 | 798 | 0.560 |
Why?
|
| Histone Deacetylase 2 | 1 | 2013 | 74 | 0.450 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2023 | 1352 | 0.440 |
Why?
|
| Histone Deacetylase 1 | 1 | 2013 | 137 | 0.430 |
Why?
|
| Lactams | 1 | 2013 | 156 | 0.430 |
Why?
|
| Neuroblastoma | 3 | 2014 | 1226 | 0.390 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2013 | 789 | 0.310 |
Why?
|
| Tympanic Membrane Perforation | 1 | 2019 | 41 | 0.170 |
Why?
|
| Epidermis | 1 | 2020 | 528 | 0.150 |
Why?
|
| Methenyltetrahydrofolate Cyclohydrolase | 1 | 2016 | 9 | 0.140 |
Why?
|
| Citric Acid Cycle | 1 | 2016 | 232 | 0.130 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 738 | 0.130 |
Why?
|
| Molecular Targeted Therapy | 3 | 2023 | 2727 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2016 | 987 | 0.110 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2016 | 651 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 2 | 2016 | 1655 | 0.100 |
Why?
|
| Oncogene Proteins | 2 | 2014 | 749 | 0.100 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2016 | 1213 | 0.100 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2013 | 473 | 0.090 |
Why?
|
| Tretinoin | 1 | 2013 | 517 | 0.090 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2012 | 430 | 0.090 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2016 | 3523 | 0.080 |
Why?
|
| Wound Healing | 1 | 2019 | 2785 | 0.080 |
Why?
|
| Stem Cells | 1 | 2020 | 3567 | 0.070 |
Why?
|
| Clinical Trials as Topic | 1 | 2023 | 7913 | 0.070 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2014 | 1660 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2013 | 8428 | 0.070 |
Why?
|
| Cell Survival | 2 | 2013 | 5882 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 2503 | 0.070 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 2109 | 0.060 |
Why?
|
| Blotting, Western | 1 | 2013 | 5179 | 0.060 |
Why?
|
| Mutation | 2 | 2023 | 29786 | 0.060 |
Why?
|
| U937 Cells | 2 | 2016 | 268 | 0.060 |
Why?
|
| HL-60 Cells | 2 | 2016 | 365 | 0.060 |
Why?
|
| Cell Line, Tumor | 3 | 2014 | 16689 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3133 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
| Nuclear Proteins | 2 | 2014 | 5853 | 0.050 |
Why?
|
| Gene Amplification | 2 | 2014 | 1063 | 0.040 |
Why?
|
| Cell Differentiation | 2 | 2013 | 11483 | 0.040 |
Why?
|
| California | 1 | 2020 | 1402 | 0.040 |
Why?
|
| Workflow | 1 | 2020 | 847 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2014 | 3557 | 0.030 |
Why?
|
| Transfection | 2 | 2014 | 5892 | 0.030 |
Why?
|
| Humans | 9 | 2023 | 744343 | 0.030 |
Why?
|
| Ribosomal Protein S6 | 1 | 2014 | 70 | 0.030 |
Why?
|
| RNA Interference | 2 | 2014 | 2889 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2014 | 11524 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2014 | 130 | 0.030 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 4 | 1 | 2013 | 9 | 0.030 |
Why?
|
| Oncogene Protein pp60(v-src) | 1 | 2013 | 77 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2013 | 12208 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2013 | 51 | 0.030 |
Why?
|
| Cell Growth Processes | 1 | 2013 | 399 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2016 | 2085 | 0.030 |
Why?
|
| Phosphotyrosine | 1 | 2013 | 457 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2013 | 234 | 0.030 |
Why?
|
| Technology, Pharmaceutical | 1 | 2012 | 84 | 0.030 |
Why?
|
| Azepines | 1 | 2013 | 336 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2019 | 10481 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2014 | 1878 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2014 | 2716 | 0.020 |
Why?
|
| Mice | 4 | 2019 | 81183 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2014 | 1119 | 0.020 |
Why?
|
| Triazoles | 1 | 2013 | 911 | 0.020 |
Why?
|
| Animals | 5 | 2019 | 168757 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 3846 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2013 | 3002 | 0.020 |
Why?
|
| Antibodies | 1 | 2013 | 2460 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2014 | 1972 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 3505 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2014 | 8436 | 0.010 |
Why?
|
| Neoplasms | 1 | 2012 | 21683 | 0.010 |
Why?
|
| Pyridines | 1 | 2014 | 2825 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 10943 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2013 | 2752 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2013 | 3462 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2013 | 5867 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8388 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2014 | 5172 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 5535 | 0.010 |
Why?
|
| Apoptosis | 1 | 2013 | 9727 | 0.010 |
Why?
|
| Genomics | 1 | 2012 | 5720 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 9438 | 0.010 |
Why?
|
| Time Factors | 1 | 2014 | 40075 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2014 | 23403 | 0.010 |
Why?
|
| Female | 2 | 2019 | 380194 | 0.000 |
Why?
|
| Child | 1 | 2013 | 77709 | 0.000 |
Why?
|
Concepts
(89)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(15)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_